Publications by authors named "Ruoqian Shen"

17Publications

Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.

Int J Oncol 2012 Oct 8;41(4):1192-8. Epub 2012 Aug 8.

Genitourinary Oncology Research Laboratory, Department of Medicine, Weill Cornell Medical College and Weill Cornell Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583657PMC
October 2012

Neutral endopeptidase is a myristoylated protein.

Mol Cell Biochem 2010 Feb 15;335(1-2):173-80. Epub 2009 Sep 15.

Genitourinary Oncology Research Laboratory, The Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11010-009-0253-8DOI Listing
February 2010

Rational redesign of neutral endopeptidase binding to merlin and moesin proteins.

Protein Sci 2009 May;18(5):1042-50

Institute of Biochemistry, Food Science and Nutrition, Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, P.O. Box 12, Rehovot 76100, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pro.114DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771306PMC
May 2009

Endothelin-1 enhances the expression of the androgen receptor via activation of the c-myc pathway in prostate cancer cells.

Mol Carcinog 2009 Feb;48(2):141-9

Urologic Oncology Laboratory, Department of Urology, Weill Cornell Medical College, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.20462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280021PMC
February 2009

Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells.

Prostate 2008 Jun;68(9):975-84

Urologic Oncology Research Laboratory, Department of Urology, Weill Cornell Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.20760DOI Listing
June 2008

Attenuation of apoptosis by chromogranin A-induced Akt and survivin pathways in prostate cancer cells.

Endocrinology 2007 Sep 21;148(9):4489-99. Epub 2007 Jun 21.

Weill Medical College of Cornell University, Department of Urology, Room E-300, Box 23, 1300 York Avenue, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2006-1748DOI Listing
September 2007

Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells.

Biochim Biophys Acta 2007 Jul 3;1773(7):1087-94. Epub 2007 May 3.

Department of Urology, Weill Medical College of Cornell University and New York Presbyterian Hospital, Rm E-300, Box 23, 1300 York Ave, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01674889070009
Publisher Site
http://dx.doi.org/10.1016/j.bbamcr.2007.04.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939980PMC
July 2007

Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression.

Cancer 2006 Dec;107(11):2628-36

Department of Urology, New York University Cancer Institute, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22312DOI Listing
December 2006

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter.

Mol Cell Endocrinol 2006 Oct 1;259(1-2):10-21. Epub 2006 Sep 1.

Division of Hematology and Medical Oncology, Department of Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, 525 E. 68th Street, ST-359, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mce.2006.07.004DOI Listing
October 2006

Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2.

J Biol Chem 2006 Nov 28;281(44):33597-605. Epub 2006 Aug 28.

Urologic Oncology Research Laboratory, Department of Urology, Weil Medical College of Cornell University-New York Presbyterian Hospital, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M602490200DOI Listing
November 2006

Involvement of neutral endopeptidase in neoplastic progression.

Biochim Biophys Acta 2005 Aug 17;1751(1):52-9. Epub 2004 Nov 17.

Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbapap.2004.11.001DOI Listing
August 2005

Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN.

Cancer Cell 2004 Jan;5(1):67-78

Urological Oncology Research Laboratory, Department of Urology, Joan and Stanford I Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1535-6108(03)00331-3DOI Listing
January 2004

Direct binding of neutral endopeptidase 24.11 to ezrin/radixin/moesin (ERM) proteins competes with the interaction of CD44 with ERM proteins.

J Biol Chem 2004 Mar 2;279(12):11898-905. Epub 2004 Jan 2.

Urologic Oncology Research Laboratory, Department of Urology, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M212737200DOI Listing
March 2004

Detection of the p110 beta subunit of phosphatidylinositol 3-kinase complexed with neutral endopeptidase.

Anticancer Res 2002 Sep-Oct;22(5):2533-8

Laboratory of Urological Oncology, Department of Urology, Joan and Sanford I. Weill Medical College of Cornell University, 1300 York Avenue, E-300 (Box 23), New York, NY 10021, USA.

View Article

Download full-text PDF

Source
February 2003

The emergence of protocadherin-PC expression during the acquisition of apoptosis-resistance by prostate cancer cells.

Oncogene 2002 Nov;21(51):7861-71

The Department of Urology, The College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205991DOI Listing
November 2002

Synergistic activation of the androgen receptor by bombesin and low-dose androgen.

Clin Cancer Res 2002 Jul;8(7):2399-405

Urologic Oncology Research Laboratory, Department of Urology, Joan and Stanford I. Weill Medical College, Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
July 2002